RxDoctor Payments Data

Laura Biehle, PA

Physician Assistant · Reno, NVNPI 1932762218

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.9%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by UCB, Inc. at 49.9% of the total. Among physician assistant clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,231in general payments, 2019–2025

Across 625 payments — averaging $57.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$18K
  • Sanofi$5K
  • AbbVie$2K
  • Regeneron Healthcare Solutions, Inc.$2K
  • Novartis$2K
  • Johnson & Johnson$1K
  • plus $6K from 24 others

What the payments were for

  • Consulting fees$9,71127%
  • Speaking & faculty fees$7,10620%
  • Travel & lodging$3,62510%
  • Food & beverage$15,54643%
  • Education$2431%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,231 in reported general payments places this provider in the 95th percentile of 881 physician assistant providers in Nevada.

See all physician assistant providers in Nevada

Medicare billing

Part B allowed, 2024
$151,610
Medicare patients
565
Services billed
3,360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab30$110,969
Fluorouracil63$4,322
Tacrolimus36$4,049
Clobetasol Propionate86$3,418
Betamethasone Dipropionate65$2,484
Desonide32$1,514
Doxycycline Hyclate49$1,030
Triamcinolone Acetonide118$901
Halobetasol Propionate12$660
Metronidazole25$651
Ketoconazole28$509
Clindamycin Phosphate15$496
ValacyclovirValacyclovir Hcl13$301
Mupirocin37$247
Hydroxyzine Hcl14$145

Paid to pharmacies, not to this prescriber.

Other physician assistant in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →